SinoNasal Microbiota Transfer to treat recalcitrant chronic rhinosinusitis: A case series-Reference-Cited by-同舟云学术

SinoNasal Microbiota Transfer to treat recalcitrant chronic rhinosinusitis: A case series

Published:2024-04-14 Issue:8 Volume:14 Page:1386-1390
ISSN:2042-6976
Container-title:International Forum of Allergy & Rhinology
language:en
Short-container-title:Int Forum Allergy Rhinol

Author:

Gill Sandeep K.¹,Hernaiz‐Leonardo Juan C.¹²^ORCID,Edens Thaddeus J.³,Pascual Athenea²,Tang Chris¹,Fan Judy²,Thamboo Andrew²,Mullings Warren⁴,Alsaleh Saad⁵,Alim Bader M.²⁶^ORCID,Javer Amin R.²^ORCID,Manges Amee R.¹⁷

Affiliation:

1. School of Population and Public Health University of British Columbia Vancouver British Columbia Canada

2. St. Paul's Sinus Centre Department of Surgery, University of British Columbia Vancouver British Columbia Canada

3. Devil's Staircase Consulting West Vancouver British Columbia Canada

4. Department of Surgery University Hospital of the West Indies Mona Jamaica

5. Department of Otolaryngology—Head and Neck Surgery King Saud University Riyadh Saudi Arabia

6. Prince Mohammed Bin Abdulaziz Hospital National Guard Health Affairs Medina Saudi Arabia

7. British Columbia Centre for Disease Control Vancouver British Columbia Canada

Abstract

Key points

SinoNasal Microbiota Transfer (SNMT) was safe with immediate benefit in all recipients, with sustained improvement in two of three recipients for up to 180 days.

The addition of antimicrobial photodynamic therapy worsened chronic rhinosinusitis.

These promising SNMT results warrant further study of safety and efficacy.

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alr.23352

Reference5 articles.

1. Cost of adult chronic rhinosinusitis: A systematic review

2. Treatment of Recalcitrant Maxillary Sinusitis With Endoscopic Modified Medial Maxillectomy: A Systematic Review of Safety and Efficacy

3. The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridiumdifficile Infection: Current Understanding and Gap Analysis

4. Early Antibiotic Use After Fecal Microbiota Transplantation Increases Risk of Treatment Failure